T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.450
-0.012 (-2.56%)
Nov 21, 2024, 11:54 AM EST - Market open
T2 Biosystems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 7.68 | 7.19 | 22.31 | 28.06 | 18.13 | 8.34 | Upgrade
|
| Revenue Growth (YoY) | -30.19% | -67.75% | -20.50% | 54.76% | 117.52% | -20.62% | Upgrade
|
| Cost of Revenue | 27.72 | 29.52 | 46.73 | 42.5 | 36.76 | 33.09 | Upgrade
|
| Gross Profit | -20.05 | -22.32 | -24.42 | -14.45 | -18.63 | -24.75 | Upgrade
|
| Selling, General & Admin | 22.84 | 24.83 | 30.63 | 28.53 | 21.57 | 27.3 | Upgrade
|
| Operating Expenses | 21.61 | 24.83 | 30.63 | 28.53 | 21.57 | 27.3 | Upgrade
|
| Operating Income | -41.66 | -47.15 | -55.05 | -42.97 | -40.2 | -52.06 | Upgrade
|
| Interest Expense | -3.19 | -5.34 | -6.08 | -7.6 | -5.52 | -7.35 | Upgrade
|
| Interest & Investment Income | 0.2 | 0.2 | - | 0.11 | 0.01 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.1 | -0.1 | -0.1 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.49 | 5.53 | -0.56 | 1 | 0.06 | 0.4 | Upgrade
|
| EBT Excluding Unusual Items | -42.25 | -46.87 | -61.79 | -49.46 | -45.64 | -59.01 | Upgrade
|
| Asset Writedown | - | -2.51 | -0.15 | - | -1.16 | - | Upgrade
|
| Other Unusual Items | -0.7 | -0.7 | -0.07 | 0.22 | - | - | Upgrade
|
| Pretax Income | -42.95 | -50.08 | -62 | -49.24 | -46.8 | -59.01 | Upgrade
|
| Net Income | -42.95 | -50.08 | -62 | -49.24 | -46.8 | -59.01 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | 0.33 | - | - | - | Upgrade
|
| Net Income to Common | -42.95 | -50.08 | -62.33 | -49.24 | -46.8 | -59.01 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 3 | 0 | 0 | 0 | - | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 3 | 0 | 0 | 0 | - | Upgrade
|
| Shares Change (YoY) | 659.51% | 5017.31% | 60.53% | 30.93% | - | - | Upgrade
|
| EPS (Basic) | -4.08 | -19.19 | -1222.14 | -1549.82 | -1928.54 | - | Upgrade
|
| EPS (Diluted) | -4.08 | -19.19 | -1222.14 | -1549.82 | -1928.54 | - | Upgrade
|
| Free Cash Flow | -36.62 | -48.33 | -50.97 | -39.33 | -44.02 | -46.12 | Upgrade
|
| Free Cash Flow Per Share | -3.48 | -18.52 | -999.31 | -1238.01 | -1814.02 | - | Upgrade
|
| Gross Margin | -261.12% | - | -109.48% | -51.49% | -102.74% | -296.99% | Upgrade
|
| Operating Margin | -542.59% | -655.54% | -246.78% | -153.16% | -221.72% | -624.57% | Upgrade
|
| Profit Margin | -559.52% | -696.19% | -279.46% | -175.50% | -258.12% | -707.93% | Upgrade
|
| Free Cash Flow Margin | -476.98% | -671.88% | -228.50% | -140.19% | -242.80% | -553.35% | Upgrade
|
| EBITDA | -41.4 | -46.29 | -54 | -41.7 | -38.49 | -49.86 | Upgrade
|
| EBITDA Margin | - | - | -242.09% | -148.63% | -212.28% | - | Upgrade
|
| D&A For EBITDA | 0.26 | 0.86 | 1.05 | 1.27 | 1.71 | 2.2 | Upgrade
|
| EBIT | -41.66 | -47.15 | -55.05 | -42.97 | -40.2 | -52.06 | Upgrade
|
| EBIT Margin | - | - | -246.78% | -153.16% | -221.72% | - | Upgrade
|
| Revenue as Reported | 7.68 | 7.19 | 22.31 | 28.06 | 18.13 | 8.34 | Upgrade
|
| Advertising Expenses | - | - | 0.1 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.